A detailed history of Baird Financial Group, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 20,430 shares of DGX stock, worth $2.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,430
Previous 22,309 8.42%
Holding current value
$2.8 Million
Previous $3.05 Million 8.29%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$137.09 - $137.09 $257,592 - $257,592
-1,879 Reduced 8.42%
20,430 $2.8 Million
Q2 2024

Aug 13, 2024

SELL
$125.91 - $144.34 $10,576 - $12,124
-84 Reduced 0.38%
22,309 $3.05 Million
Q1 2024

May 14, 2024

SELL
$123.78 - $142.11 $7.35 Million - $8.44 Million
-59,362 Reduced 72.61%
22,393 $2.98 Million
Q4 2023

Feb 14, 2024

SELL
$120.62 - $141.12 $318,316 - $372,415
-2,639 Reduced 3.13%
81,755 $11.3 Million
Q3 2023

Nov 13, 2023

SELL
$121.86 - $144.92 $1.9 Million - $2.26 Million
-15,589 Reduced 15.59%
84,394 $10.3 Million
Q2 2023

Aug 11, 2023

BUY
$130.56 - $146.84 $8.15 Million - $9.17 Million
62,441 Added 166.32%
99,983 $14.1 Million
Q1 2023

May 15, 2023

SELL
$131.53 - $155.76 $1.69 Million - $2 Million
-12,865 Reduced 25.52%
37,542 $5.31 Million
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $52,361 - $60,673
430 Added 0.82%
52,980 $6.5 Million
Q2 2022

Aug 08, 2022

SELL
$127.07 - $145.39 $10.7 Million - $12.3 Million
-84,454 Reduced 61.64%
52,550 $6.99 Million
Q1 2022

May 13, 2022

BUY
$129.09 - $164.35 $10.6 Million - $13.4 Million
81,806 Added 148.2%
137,004 $18.7 Million
Q4 2021

Feb 09, 2022

BUY
$140.36 - $173.01 $146,676 - $180,795
1,045 Added 1.93%
55,198 $9.55 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $217,506 - $258,488
1,636 Added 3.12%
54,153 $7.87 Million
Q2 2021

Aug 11, 2021

SELL
$126.66 - $141.48 $386,439 - $431,655
-3,051 Reduced 5.49%
52,517 $6.93 Million
Q1 2021

May 13, 2021

SELL
$114.63 - $133.34 $83,565 - $97,204
-729 Reduced 1.29%
55,568 $7.13 Million
Q4 2020

Feb 11, 2021

SELL
$112.7 - $128.05 $1.67 Million - $1.9 Million
-14,806 Reduced 20.82%
56,297 $6.71 Million
Q3 2020

Nov 12, 2020

BUY
$107.05 - $130.01 $323,291 - $392,630
3,020 Added 4.44%
71,103 $8.14 Million
Q2 2020

Oct 22, 2020

SELL
$73.34 - $122.61 $4.77 Million - $7.98 Million
-65,057 Reduced 48.86%
68,083 $7.76 Million
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $3.4 Million - $5.69 Million
-46,386 Reduced 25.84%
133,140 $14.2 Million
Q1 2020

May 14, 2020

BUY
$75.14 - $115.68 $1.28 Million - $1.97 Million
17,004 Added 10.46%
179,526 $14.4 Million
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $2.87 Million - $3.09 Million
28,612 Added 21.37%
162,522 $17.4 Million
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $6.1 Million - $6.7 Million
62,346 Added 87.12%
133,910 $14.3 Million
Q2 2019

Aug 14, 2019

SELL
$85.18 - $101.94 $4.64 Million - $5.55 Million
-54,484 Reduced 43.22%
71,564 $7.29 Million
Q1 2019

May 14, 2019

BUY
$80.68 - $89.92 $7.22 Million - $8.05 Million
89,537 Added 245.23%
126,048 $11.3 Million
Q4 2018

Feb 14, 2019

BUY
$79.75 - $108.38 $2.42 Million - $3.29 Million
30,331 Added 490.79%
36,511 $3.04 Million
Q3 2018

Nov 13, 2018

BUY
$105.42 - $114.99 $11,807 - $12,878
112 Added 1.85%
6,180 $670,000
Q2 2018

Aug 13, 2018

SELL
$97.35 - $113.14 $303,537 - $352,770
-3,118 Reduced 33.94%
6,068 $667,000
Q1 2018

May 14, 2018

BUY
$96.42 - $107.88 $429,454 - $480,497
4,454 Added 94.13%
9,186 $921,000
Q4 2017

Feb 09, 2018

BUY
$90.86 - $100.24 $159,913 - $176,422
1,760 Added 59.22%
4,732 $466,000
Q3 2017

Nov 14, 2017

SELL
$91.96 - $108.35 $1,655 - $1,950
-18 Reduced 0.6%
2,972 $278,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,990
2,990 $332,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.